Patrick Yang
Founder at ACEPODIA, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Dr. Patrick Y.
Yang is an Independent Director at Sana Biotechnology, Inc., a Chairman, Chief Strategy Officer & Deputy GM at Acepodia, Inc., a Chairman at Acepodia, Inc. (United States), an Independent Director at PharmaEssentia Corp., a Chairman at AbGenomics International, Inc. and a Chairman at Altrubio, Inc. He is on the Board of Directors at Sana Biotechnology, Inc., Acepodia Biotechnologies, Ltd., PharmaEssentia Corp., Antheia, Inc., Archigen Biotech Ltd., Aspen Sciences LLC, Taiwania Capital Management USA, Inc., Tetra Tech Tesoro, Inc. and National Resilience, Inc. Dr. Yang was previously employed as an Executive Vice President by Juno Therapeutics, Inc., an Independent Director by Amyris, Inc., an Independent Director by Celladon Corp., an Independent Director by Codexis, Inc., an Independent Director by Andeavor, an EVP & Head-Pharmaceutical Technical Operations by F.
Hoffmann-La Roche Ltd., an Executive Vice President-Product Operations by Genentech, Inc., a VP-Asia & Pacific Manufacturing Operations by Merck & Co., Inc., a Principal by General Electric Co., and a Principal by Life Systems, Inc. He also served on the board at TaiMed, Inc. and Polaris Pharmaceuticals, Inc. He received his undergraduate degree from National Chiao Tung University, a graduate degree from the University of Cincinnati (Ohio) and a doctorate degree from The Ohio State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC.
0.07% | 2024-03-31 | 149,250 ( 0.07% ) | 1 M $ | 2024-04-29 |
Patrick Yang active positions
| Companies | Position | Start |
|---|---|---|
| PHARMAESSENTIA CORPORATION | Director/Board Member | 2014-02-28 |
| SANA BIOTECHNOLOGY, INC. | Director/Board Member | 2018-09-30 |
| ACEPODIA, INC. | Founder | 2017-02-14 |
| Aspen Sciences LLC | Director/Board Member | - |
AbGenomics International, Inc.
 AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Chairman | - |
Altrubio, Inc.
 Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Chairman | - |
Antheia, Inc.
 Antheia, Inc. Pharmaceuticals: OtherHealth Technology Antheia, Inc. provides supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines. The company was founded by Kristy Hawkins, Christina Smolke, Kate Thodey, and Isis Trenchard. The company is headquartered in Menlo Park, CA. | Director/Board Member | - |
National Resilience, Inc.
 National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Director/Board Member | - |
Archigen Biotech Ltd.
 Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Director/Board Member | 2014-06-08 |
| ░░░░░ ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Former positions of Patrick Yang
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Patrick Yang
| The Ohio State University | Doctorate Degree |
| University of Cincinnati (Ohio) | Graduate Degree |
| National Chiao Tung University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| GE AEROSPACE | Producer Manufacturing |
| MERCK & CO., INC. | Health Technology |
| CODEXIS, INC. | Process Industries |
| AMYRIS, INC. | Process Industries |
| PHARMAESSENTIA CORPORATION | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| ACEPODIA, INC. | Health Technology |
| Private companies | 17 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Andeavor LLC
 Andeavor LLC Oil Refining/MarketingEnergy Minerals Andeavor engages in the refining and marketing of petroleum products. It operates through the following segments: Refining, Logistics, and Marketing. The Refining segment buys and refines crude oil and other feed stocks into transportation fuels, such as gasoline and gasoline blend stocks, jet fuel and diesel fuel, as well as other products, including heavy fuel oils, liquefied petroleum gas and petroleum coke for sale in bulk markets to a wide variety of customers within Andeavor's markets. The logistics segment includes crude oil and natural gas gathering assets, natural gas and natural gas liquid processing assets, and crude oil and refined products terminalling, transportation and storage assets acquired from Andeavor and third parties. The Marketing segment sells transportation fuels through branded and unbranded channels. Its brand portfolio includes ARCO, Shell, Exxon, Mobil, USA Gasoline, Rebel, and Tesoro. The company was founded by West V. Robert, Jr. in 1964 and is headquartered in San Antonio, TX. | Energy Minerals |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Health Technology |
Antheia, Inc.
Antheia, Inc. Pharmaceuticals: OtherHealth Technology Antheia, Inc. provides supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines. The company was founded by Kristy Hawkins, Christina Smolke, Kate Thodey, and Isis Trenchard. The company is headquartered in Menlo Park, CA. | Health Technology |
Life Systems, Inc.
 Life Systems, Inc. Services to the Health IndustryHealth Services Life Systems Corp. is a biotech company, which researches, develops and sells organ preservation device technology. The company was founded by Fereydoon Sadri in 1994 and is headquartered in Redmond, WA. | Health Services |
Tetra Tech Tesoro, Inc.
 Tetra Tech Tesoro, Inc. Engineering & ConstructionIndustrial Services Tetra Tech Tesoro, Inc. provides construction services. It also build schools, hospitals, and clinics for selected commercial and private clients. The company was founded on June 4, 1997 and is headquartered in Virginia Beach, VA. | Industrial Services |
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
| TaiMed, Inc. | |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Taiwania Capital Management USA, Inc. | |
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Health Technology |
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Retail Trade |
National Resilience, Inc.
National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Commercial Services |
| Aspen Sciences LLC |
- Stock Market
- Insiders
- Patrick Yang
